Ltd4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Asthma and Virus Diseases. The involved functions are known as uptake, Phosphorylation, Signal Transduction, symporter activity and Regulation. Ltd4 often locates in Protoplasm, Mucous Membrane, Membrane, Extracellular and Epithelium. The associated genes with Ltd4 are TYRO3 gene, RAF1 gene, serine-borate complex, ITGAM gene and ITGB2 gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of Ltd4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ltd4?

Ltd4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Ltd4

MeSH term MeSH ID Detail
Airway Obstruction D000402 13 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Leukemia D007938 74 associated lipids
Glomerulonephritis D005921 35 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Carotid Stenosis D016893 15 associated lipids
Asthma, Exercise-Induced D001250 10 associated lipids
Endotoxemia D019446 27 associated lipids
Per page 10 20 | Total 13

PubChem Associated disorders and diseases

What pathways are associated with Ltd4

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ltd4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ltd4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ltd4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ltd4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ltd4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Ltd4

Download all related citations
Per page 10 20 50 100 | Total 562
Authors Title Published Journal PubMed Link
Hazel BA et al. Induction of granulocytic differentiation in a mouse model by benzene and hydroquinone. 1996 Environ. Health Perspect. pmid:9118902
Takano T et al. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. 1997 J. Exp. Med. pmid:9151906
Pedersen KE et al. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. 1997 J. Pharmacol. Exp. Ther. pmid:9152370
Joki S et al. Effect of leukotriene D4 on ciliary activity in human, guinea-pig and rat respiratory mucosa. 1996 Pulm Pharmacol pmid:9160411
Goldhill J et al. Interleukin-4 modulates cholinergic neural control of mouse small intestinal longitudinal muscle. 1997 Am. J. Physiol. pmid:9176223
Meng XJ et al. Leukotriene D4 activates a chloride conductance in hepatocytes from lipopolysaccharide-treated rats. 1997 J. Clin. Invest. pmid:9185515
Sampson SE et al. Effect of inhaled prostaglandin D2 in normal and atopic subjects, and of pretreatment with leukotriene D4. 1997 Thorax pmid:9227716
O'Shaughnessy TC et al. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers. 1997 Thorax pmid:9227717
Honda I et al. Tachykinin antagonist FK224 inhibits neurokinin A-, substance P- and capsaicin-induced human bronchial contraction. 1997 Fundam Clin Pharmacol pmid:9243258
Kanli H and Terreros DA Transepithelial transport and cell volume control in proximal renal tubules from the teleost Carassius auratus. 1997 Acta Physiol. Scand. pmid:9246390
Cincu RN et al. S-adenosyl-L-methionine protects the liver against the cholestatic, cytotoxic, and vasoactive effects of leukotriene D4: a study with isolated and perfused rat liver. 1997 Hepatology pmid:9252142
Spector SL Leukotriene activity modulation in asthma. 1997 Drugs pmid:9279501
Wong WS et al. Effects of tyrosine kinase inhibitors on antigen challenge of guinea pig lung in vitro. 1997 J. Pharmacol. Exp. Ther. pmid:9336317
Beckh K et al. Effects of nitric oxide on leukotriene D4 decreased bile secretion in the perfused rat liver. 1997 Life Sci. pmid:9364199
Kagoshima M et al. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. 1997 Pharmacology pmid:9380772
Cibulsky SM and Thompson DC Absence of tachykinin involvement in leukotriene D4 and antigen-induced contraction of guinea pig isolated bronchus. 1997 J. Pharmacol. Exp. Ther. pmid:9399982
Gorenne I et al. Leukotriene D4 contractions in human airways are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry. 1998 J. Pharmacol. Exp. Ther. pmid:9454796
Fujita M et al. Cysteinyl leukotrienes induce nasal symptoms of allergic rhinitis via a receptor-mediated mechanism in guinea pigs. 1997 Jpn. J. Pharmacol. pmid:9469641
Hoshino M et al. Leukotriene D4 activates mitogen-activated protein kinase through a protein kinase Calpha-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells. 1998 J. Biol. Chem. pmid:9478929
Francis HP et al. The effects of a novel sulphidopeptide leukotriene antagonist, BAY x7195, against elicited bronchoconstriction in the anaesthetized guinea-pig. 1998 Br. J. Pharmacol. pmid:9484852
Yamaya M et al. Dipeptidase inhibitor and epithelial removal potentiate leukotriene D4-induced human tracheal smooth muscle contraction. 1998 Respir Physiol pmid:9496476
Basavappa S et al. Swelling-induced arachidonic acid release via the 85-kDa cPLA2 in human neuroblastoma cells. 1998 J. Neurophysiol. pmid:9497423
Capra V et al. Pharmacological characterization of the cysteinyl-leukotriene antagonists CGP 45715A (iralukast) and CGP 57698 in human airways in vitro. 1998 Br. J. Pharmacol. pmid:9504401
Kimura K et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. 1998 J. Biochem. pmid:9504421
Daugschies A and Ruttkowski B Modulation of migration of Oesophagostomum dentatum larvae by inhibitors and products of eicosanoid metabolism. 1998 Int. J. Parasitol. pmid:9513001
Capra V et al. Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. 1998 Mol. Pharmacol. pmid:9547367
Przylipiak A et al. Influence of leukotrienes on in vitro growth of human mammary carcinoma cell line MCF-7. 1998 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:9550202
Zwaagstra ME et al. Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists. 1998 J. Med. Chem. pmid:9554876
Cyrus CB et al. Leukotrienes C4 and D4 increase the ciliary beat frequency in human upper airway mucosa in vitro. 1998 Otolaryngol Head Neck Surg pmid:9560097
Habib GM et al. Leukotriene D4 and cystinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9560193
Dahlén B et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. 1998 Am. J. Respir. Crit. Care Med. pmid:9563738
Jonsson EW Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle. 1998 Acta Physiol Scand Suppl pmid:9597121
Sato E et al. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. 1998 Am. J. Physiol. pmid:9609736
Ohbayashi H et al. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model. 1998 Eur. J. Pharmacol. pmid:9617752
Kohno S [Role of peptide-leukotrienes in bronchial asthma]. 1998 Nippon Yakurigaku Zasshi pmid:9618707
Nagase T and Ludwig MS Antigen-induced responses in lung parenchymal strips during sinusoidal oscillation. 1998 Can. J. Physiol. Pharmacol. pmid:9635157
Allen S et al. Differential leukotriene constrictor responses in human atherosclerotic coronary arteries. 1998 Circulation pmid:9641692
Traianedes K et al. 5-Lipoxygenase metabolites inhibit bone formation in vitro. 1998 Endocrinology pmid:9645691
Liu YC et al. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro. 1998 Br. J. Pharmacol. pmid:9647482
Smith LJ et al. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy. 1998 Ann. Allergy Asthma Immunol. pmid:9690572
Shirasaki H et al. The effect of a cysteinyl leukotriene antagonist, ONO-1078 (pranlukast) on agonist- and antigen-induced nasal microvascular leakage in guinea pigs. 1998 Rhinology pmid:9695159
Massoumi R and Sjölander A The inflammatory mediator leukotriene D4 triggers a rapid reorganisation of the actin cytoskeleton in human intestinal epithelial cells. 1998 Eur. J. Cell Biol. pmid:9716265
Panettieri RA et al. Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9730873
Geirsson A et al. Potentiating effects of pertussis toxin on leukotriene C4 induced formation of inositol phosphate and prostacyclin in human umbilical vein endothelial cells. 1998 J. Cell. Physiol. pmid:9731750
Nagayama S et al. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078. 1998 Cancer Lett. pmid:9751271
Kim N et al. Leukotriene D4-induced contraction of cat esophageal and lower esophageal sphincter circular smooth muscle. 1998 Gastroenterology pmid:9753495
Wen FQ et al. Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1 beta and TNF alpha. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9758210
Tsang F et al. Effects of mitogen-activated protein kinase kinase inhibitor PD 098059 on antigen challenge of guinea-pig airways in vitro. 1998 Br. J. Pharmacol. pmid:9776345
Grönroos E et al. Leukotriene D4 induces a rapid increase in cAMP in the human epithelial cell line, Int 407: a potential role for this signal in the regulation of calcium influx through the plasma membrane. 1998 Cell Calcium pmid:9793684
Sciuto AM et al. Post-exposure treatment with isoproterenol attenuates pulmonary edema in phosgene-exposed rabbits. 1998 Sep-Oct J Appl Toxicol pmid:9804432
Arakida Y et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors. 1998 J. Pharmacol. Exp. Ther. pmid:9808690
Kjellström S et al. On-line coupling of microdialysis sampling with liquid chromatography for the determination of peptide and non-peptide leukotrienes. 1998 J Chromatogr A pmid:9818423
Fujimura M et al. A partial involvement of histamine in ultrasonically nebulized distilled water-induced bronchoconstriction in guinea-pigs. 1998 Br. J. Pharmacol. pmid:9831931
Kawashima Y et al. Surface-modified antiasthmatic dry powder aerosols inhaled intratracheally reduce the pharmacologically effective dose. 1998 Pharm. Res. pmid:9833999
Lane SJ Leukotriene antagonism in asthma and rhinitis. 1998 Respir Med pmid:9850362
Underwood DC et al. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. 1998 J. Pharmacol. Exp. Ther. pmid:9864284
Venugopalan CS et al. Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease. 1998 Vet. Res. Commun. pmid:9868763
von Sprecher A et al. Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class. 1998 Bioorg. Med. Chem. Lett. pmid:9871521
Chambers RJ et al. Development of new chromanol antagonists of leukotriene D4. 1998 Bioorg. Med. Chem. Lett. pmid:9873435
Yang XX et al. Strain dependence of the airway response to dry-gas hyperpnea challenge in the rat. 1999 J. Appl. Physiol. pmid:9887125
Ohbayashi H et al. Neutral endopeptidase 3.4.24.11 inhibition potentiates the inhibitory effects of type-C natriuretic peptide on leukotriene D4-induced airway changes. 1998 Clin. Exp. Pharmacol. Physiol. pmid:9887994
Lärfars G et al. Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes. 1999 Blood pmid:9949184